Physician profile
Kathleen Lin
NPI 1336294362
$20,040.36
in general payments reported to CMS, 2019-2025
8 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.92 · 2021: $24.54 · 2022: $12.56 · 2023: $334 · 2024: $191 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,600 · Consulting Fee: $6,325 · Travel and Lodging: $5,192 · Food and Beverage: $1,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,600.00 |
| Consulting Fee | $6,325.02 |
| Travel and Lodging | $5,192.09 |
| Food and Beverage | $1,842.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Sa De Cv | $12,093.94 | 2025 | |
| Ferring Pharmaceuticals INC. | $7,245.77 | 2023-2025 | Menopur, Endometrin |
| Organon LLC | $294.83 | 2022-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Emd Serono, INC. | $178.84 | 2019-2025 | |
| Coopersurgical, INC. | $151.91 | 2023 | Stripper |
| Merck Sharp & Dohme LLC | $43.35 | 2019-2021 | |
| Karl Storz Endoscopy-America | $16.73 | 2025 | |
| Meditrina | $14.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.